Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine.

ABSTRACT:

Background

Herpes zoster vaccination rates remain low despite longstanding national recommendations to vaccinate immunocompetent adults aged ≥ 50 years. The Advisory Committee on Immunization Practice (ACIP) updated its recommendations for recombinant zoster vaccine (RZV) in October 2021 to include immunocompromised adults aged ≥19 years.

Objective

To assess practices, attitudes, and knowledge about RZV, barriers to recommending RZV, and likelihood of recommending RZV to patients with various immunocompromising conditions.

Design

Mail and internet-based survey conducted from May through July 2020.

Participants

General internists and family physicians throughout the USA.

Main measures

Survey responses.

Key results

The response rate was 66% (632/955

SUBMITTER: Hurley LP 

PROVIDER: S-EPMC9261227 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature